Lacosamide Solution
Product Images NDC 70954-488

6 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70954-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient Lacosamide, showing its molecular configuration with key functional groups and bonds, associated with the oral solution dosage form by ANI Pharmaceuticals, Inc.*
FDA Label Image

Figure1 (Figure 1)

Figure1 (Figure 1)
A bar chart depicting seizure reduction median percentage change from baseline across three studies testing Lacosamide at varying doses (200, 400, 600 mg/day) compared with placebo. The chart shows higher seizure reduction in Lacosamide groups versus placebo, with statistical significance noted by asterisks.*
FDA Label Image

Figure2 (Figure 2)

Figure2 (Figure 2)
A response rate graph comparing placebo and three dosages of Lacosamide (200 mg/day, 400 mg/day, and 600 mg/day) showing percent of patients on the horizontal axis and responder rate (equal to or greater improvement) on the vertical axis. The graph plots response curves for placebo and Lacosamide dosages illustrating differences in patient improvement or worsening.*
FDA Label Image

Fig-3 (Fig 3)

Fig-3 (Fig 3)
A Kaplan-Meier survival curve comparing the proportion of patients over time (days) between placebo and lacosamide treatment groups. The chart includes hazard ratio, p-value, and confidence interval data, with patient numbers at risk displayed below the time axis.*
FDA Label Image
FDA Label Image

Label (Label)

Label (Label)
Lacosamide Oral Solution USP 10 mg/mL in a 200 mL bottle distributed by ANI Pharmaceuticals, Inc. The label includes storage instructions, dosage reminder, a barcode, and a notice for pharmacists to provide the Medication Guide to patients. The product is for oral use and requires a prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.